Skip to main content
Log in

Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Nanni C, Cottereau AS, Lopci E, Bodet-Milin C, Coronado M, Pro B, et al. Report of the 6th international workshop on PET in lymphoma. Leuk Lymphoma. 2017;7:1–6.

    Google Scholar 

  2. Barrington SF, Kluge R. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):97–110.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hasenclever D, Kurch L, Mauz-Körholz C, Elsner A, Georgi T, Wallace H, et al. qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging. 2014;41:1301–8.

    Article  PubMed  Google Scholar 

  4. Annunziata S, Cuccaro A, Calcagni ML, Hohaus S, Giordano A, Rufini V. Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET). Ann Nucl Med. 2016;30(8):588–92.

    Article  CAS  PubMed  Google Scholar 

  5. Laffon E, Marthan R. FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET. Eur J Nucl Med Mol Imaging. 2017;44(9):1602–3.

    Article  PubMed  Google Scholar 

Download references

Funding

Nothing to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Salvatore Annunziata.

Ethics declarations

Conflict of interest

Nothing to declare.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Annunziata, S., Calcagni, M.L., Indovina, L. et al. Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan. Eur J Nucl Med Mol Imaging 44, 2140–2141 (2017). https://doi.org/10.1007/s00259-017-3819-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-017-3819-9

Navigation